LESLIE BATTY: Open Payments
NPI 1073675021 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 23 payments from 14 companies in 2025. Trend: 2023 $66 · 2024 $276 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| ABBVIE INC. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 2 | $34 |
| Dexcom, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
Products named: Ozempic, FANAPT, CAPLYTA, VRAYLAR, SHINGRIX, MOUNJARO, Dexcom G6 Transmitter, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
